- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 1.37M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $13K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $3.16M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $4.24M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.22M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.56M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.09M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $7.29M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $8.85M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $9.24M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $12.99M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $13.52M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $0 |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $6K |
| Operating Cash Flow | Q1 2025 · Dec 31, 2024 | −$9.6M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$3.21M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 1.36M sh |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$1.78 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$1.78 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $2.06M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$2.42M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$1.59M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $471K |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $987K |